Hyperhomocysteinemia and cardiovascular disease in uremia: The newest evidence in epidemiology and mechanisms of action

Seminars in Nephrology

Volumn 24, Issue 5, 2004, Pages 426-430

  Perna, Alessandra F ^a   Acanfora, Filomena ^a   Satta, Ersilia ^a   Lombardi, Cinzia ^a   Ingrosso, Diego ^a   De Santo, Natale G ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

chronic renal failure; folate therapy; homocysteine; hypomethylation; uremia

Indexed keywords

FOLIC ACID; HOMOCYSTEINE;

ACYLATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC DISEASE; CLINICAL TRIAL; CONFERENCE PAPER; DIET THERAPY; DIETARY INTAKE; DISEASE ASSOCIATION; DNA METHYLATION; GENE EXPRESSION REGULATION; HOMOCYSTINURIA; HUMAN; HYPERHOMOCYSTEINEMIA; HYPOTHESIS; KIDNEY FAILURE; METHYLATION; NITROSYLATION; OXIDATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN METHYLATION; PROTEIN PROCESSING; RISK FACTOR; UREMIA;

CARDIOVASCULAR DISEASES; HUMANS; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE, CHRONIC; UREMIA;

EID: 5444244466     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2004.06.019     Document Type: Conference Paper

References (35)

1. P.M. Ueland, H. Refsum, S.A.A. Beresford The controversy over homocysteine and cardiovascular risk Am J Clin Nutr 72 2000 324 332
2. Homocysteine Studies Collaboration Homocysteine and risk of ischemic heart disease and stroke JAMA 288 2002 2015 2022
3. S.S. Kang, P.W.K. Wong, M.R. Malinow Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease Ann Rev Nutr 12 1992 279 298
4. R. Clarke, L. Daly, K. Robinson Hyperhomocysteinemia An independent risk factor for vascular disease N Engl J Med 324 1991 1149 1155
5. K.S. McCully Vascular pathology of homocysteinemia Implications for the pathogenesis of atherosclerosis Am J Pathol 56 1969 111 128
6. D.E.L. Wilcken, B. Wilcken The natural history of vascular disease in homocystinuria and the effects of treatment J Inherit Metab Dis 20 1997 295 300
7. M. Klerk, P. Verhoef, R. Clarke MTHFR Studies Collaboration Group MTHFR 677C→T polymorphism and risk of coronary heart disease A meta-analysis JAMA 288 2002 2023 2031
8. A.F. Perna, P. Castaldo, D. Ingrosso Homocysteine, a new cardiovascular risk factor, is also a powerful uremic toxin J Nephrol 12 1999 230 240
9. H. Refsum, S. Helland, P.M. Ueland Radioenzymic determination of homocysteine in plasma and urine Clin Chem 31 1985 624 628
10. A.B. Guttormsen, P.M. Ueland, E. Svarstad Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure Kidney Int 52 1997 495 502
11. W.E. Mitch, V.U. Collier, M. Walser Creatinine metabolism in chronic renal failure Clin Sci 58 1980 327 335
12. A.G. Bostom, J.T. Brosnan, B. Hall Net uptake of plasma homocysteine by the rat kidney in vivo Atherosclerosis 116 1995 59 62
13. C. Van Guldener, A.J.M. Donker, C. Jakobs No net renal extraction of homocysteine in fasting humans Kidney Int 54 1996 166 199
14. H. Ghandour, P.J. Bagley, D. Shemin Distribution of plasma folate forms in hemodialysis patients receiving high daily doses of L-folinic or folic acid Kidney Int 62 2003 2246 2249
15. 12 Nephrol Dial Transplant 17 2002 865 870
16. G. Garibotto, A. Sofia, S. Saffioti Inter-organ exchange of aminothiols in humans Am J Physiol 284 2003 E757 E763
17. H.J. Blom, S. De Vriese Why are homocysteine levels increased in kidney failure? A metabolic approach J Lab Clin Med 139 2002 262 268
18. J.T. Brosnan Homocysteine and the kidney R. Carmel D. Jacobsen Homocysteine in Health and Disease 2001 Cambridge University Press Cambridge, UK 176 182
19. J.W. Foreman, H. Wald, G. Blumberg Homocystine uptake in isolated rat renal cortical tubules Metabolism 31 1982 613 619
20. A.N. Friedman, A.G. Bostom, J. Selhub The kidney and homocysteine metabolism J Am Soc Nephrol 12 2001 2181 2189
21. G. Schnyder, M. Roffi, R. Pin Decreased rate of coronary restenosis after lowering of plasma homocysteine levels N Engl J Med 345 2001 1593 1600
22. A.G. Bostom, J. Selhub, P.F. Jacques Power shortage Clinical trials testing the "homocysteine hypothesis" against a background of folic acid-fortified cereal grain flour Ann Intern Med 135 2001 133 137
23. R. Clarke Large trials of folic acid supplementation for prevention of cardiovascular disease J Inherit Metab Dis 26 suppl 1 2003 10 abstr
24. F. Mallamaci, C. Zoccali, G. Tripepi CREED Investigators Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients Kidney Int 61 2002 609 614
25. M.E. Suliman, A.R. Qureshi, P. Barany Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients Kidney Int 57 2000 1727 1735
26. K. Kalantar-Zadeh, G. Block, M.H. Humphreys Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients Kidney Int 63 2003 793 808
27. G.S. Hossain, J.V. vanThienen, G. Werstuck TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death and contributes to the development of atherosclerosis in hyperhomocysteinemia J Biol Chem 278 2003 30317 31327
28. D. Ingrosso, A. Cimmino, A.F. Perna Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uremia Lancet 361 2003 1693 1699
29. A.F. Perna, D. Ingrosso, P. Galletti Enzymatic methyl esterification of erythrocyte membrane proteins is impaired in chronic renal failure. Evidence for high levels of the natural inhibitor S-adenosylhomocysteine J Clin Invest 91 1993 2497 2503
30. A.F. Perna, D. Ingrosso, N.G. De Santo Mechanism of erythrocyte accumulation of methylation inhibitor S-adenosylhomocysteine in uremia Kidney Int 47 1995 247 253
31. A.F. Perna, A. D'Aniello, J.D. Lowenson D-aspartate content of erythrocyte membrane proteins is decreased in uremia Implications for the repair of damaged proteins J Am Soc Nephrol 8 1997 95 104
32. S. Clarke, K. Banfield S-adenosylmethionine-dependent methyltransferases R. Carmel D. Jacobsen Homocysteine in Health and Disease 2001 Cambridge University Press Cambridge, UK 63 78
33. JakubowskiH Biosynthesis and reactions of homocysteine thiolactone R. Carmel D. Jacobsen Homocysteine in Health and Disease 2001 Cambridge University Press Cambridge, UK 21 31
34. G. Sunder-Plassmann, M. Födinger, H. Buchmayer Effect of high dose folic acid therapy on hyperhomocysteinemia in hemodialysis patients Results of the Vienna multicenter study J Am Soc Nephrol 11 2000 1106 1116
35. Z.A. Massy Potential strategies to normalize the levels of homocysteine in chronic renal failure patients Kidney Int 63 2003 S134 S136